HDFC Life Insurance Company Ltd

HDFC Life Insurance Company Ltd has announced that its Board of Directors will convene on October 15, 2026. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Additionally, the board will discuss and approve the raising of funds through the issuance of Non-Convertible Debentures (subordinated debt) on a private placement basis. In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, a trading window closure has been implemented from October 1, 2026, to October 17, 2026, for designated persons and their relatives.

HDFC Life Insurance Company Ltd announced that its Nomination & Remuneration Committee has approved the grant of 2,385,355 equity stock options and 1,105,140 performance restricted stock units. The stock options have a face value of Rs. 10 and a grant price of Rs. 531.60, vesting over three years (30%, 30%, 40%) and exercisable within four years of vesting. The restricted stock units also have a face value of Rs. 10 and a grant price of Rs. 10, with identical vesting schedules and exercise periods. These grants are made under the Employee Stock Option Scheme 2025 and Performance Restricted Stock Units Scheme 2025, respectively.

HDFC Life Insurance Company Ltd has received an Appeal Order from the Commissioner (Appeals-III), CGST & Central Excise, Mumbai, confirming a total tax demand of Rs 942.18 crore, along with applicable interest and a penalty of Rs 2,422.97 crore. This order pertains to the period July 1, 2017, to March 31, 2022. The company stated that this order will not have any adverse material impact on its financial operations and intends to contest it further by filing an appeal before the GST Appellate Tribunal.

HDFC Life Insurance Company Ltd has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the re-appointment of its key management personnel. Ms. Vibha Padalkar has been re-appointed as Managing Director & Chief Executive Officer for a further term of 5 years, effective September 12, 2026. Mr. Niraj Shah has been re-appointed as Executive Director & Chief Financial Officer for a further term of 5 years, effective April 26, 2026. These re-appointments were recommended by the Nomination & Remuneration Committee and approved by the Board of Directors, with shareholders also giving their assent at the Annual General Meeting held on July 16, 2026.

HDFC Life Insurance Company Ltd announced that Mr. Sumit Bose will be stepping down as an Independent Director on July 18, 2026, upon completing his maximum tenure of two consecutive five-year terms. The Board of Directors expressed gratitude for his contributions and guidance during his service. This change is in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

HDFC Life Insurance Company Ltd has filed a statement confirming no deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026. The funds, amounting to approximately ₹1,000 crore raised on June 16, 2026, were utilized in line with the stated objects. The Audit Committee reviewed the statement on July 15, 2026, and found no discrepancies. This filing is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

HDFC Life Insurance Company Ltd reported its financial results for the quarter ended June 30, 2026. The company's Value of New Business (VNB) grew by 9% year-on-year to ₹879 crore, with a New Business Margin of 25.0%. Profit After Tax (PAT) increased by 12% to ₹611 crore. Assets Under Management (AUM) crossed ₹5.7 lakh crore. The company highlighted strong growth in its protection business, with retail protection growing 42%. Management expressed confidence in sustained long-term growth, driven by India's underpenetrated life insurance market and the company's focus on protection-led products and professional distribution.

HDFC Life reported consolidated Q1 FY27 (quarter ended June 30, 2026) profit after tax of ₹611.2 Cr, up 11.5% year-on-year from ₹548.4 Cr, on shareholders'-account total income of ₹760.7 Cr (+7.1% YoY). The bottom line grew faster than this tracked topline, nudging the shareholders'-account net margin to ~80% from ~77% a year ago, though that line is dominated by volatile investment income and surplus transfers and is a poor guide to underlying economics. The operating engine looks healthier than the headline: net premium income rose ~15% YoY to ₹16,727.6 Cr, with first-year premium up 7.3% to ₹2,746 Cr — the growth story analysts actually watch. Standalone PAT of ₹611.4 Cr is effectively identical to consolidated, so the subsidiaries (pension, international life/re) are immaterial to profit. The blemish is cost. The Expenses of Management ratio climbed to 22.5% from 21.9% a year ago, the GST/fixed-cost drag management had flagged on the FY26 call, where it guided the GST margin headwind to be fully neutralized in H1 FY27 and VNB margin to recover toward 25% over time. This filing is the SEBI financial result and does not carry APE or VNB, so those guidance checkpoints cannot be verified here and land in the investor presentation/concall — treat the guidance verdict as open. Separately, a deeply negative policyholders' investment line (-₹6,488 Cr) reflects equity-market mark-to-market on ULIP funds during the quarter; it is offset by a ₹21,068 Cr change in actuarial liability and does not touch shareholder profit, but it explains why the policyholders' 'Total income' optics look distorted. On the balance sheet, solvency stands at 185% — down from 192% a year ago but up sharply from 177% at end-Q4 — helped by a ₹1,000 Cr preferential capital raise from promoter HDFC Bank (1.45 Cr shares at ₹688.52). A ₹265.4 Cr GST demand is being contested at the Tribunal (contingent liabilities ₹1,866 Cr). The Board also put the ₹2.10 FY26 final dividend up for approval at the July 16 AGM. Street has no formal quarterly PAT consensus for insurers (they model APE/VNB); brokerages build FY27 APE growth of ~11% and VNB margin recovery to ~24.7%, against a consensus target near ₹820.

HDFC Life Insurance Company Ltd has announced its earnings conference call for analysts and investors to discuss the financial performance for the quarter ended June 30, 2026 (Q1FY27). The call is scheduled for Wednesday, July 15, 2026, at 16:30 IST. Participants can pre-register via a provided link to receive dial-in details, passcode, and PIN, or use the universal access numbers with operator assistance. An audio recording will be available on the company's website post-event.

HDFC Life Insurance Company Ltd has announced that its Board of Directors will convene on July 15, 2026. The primary agenda item for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. In conjunction with this announcement, the company has also informed about a trading window closure for its securities. This closure will be effective from July 1, 2026, and will extend until July 17, 2026, inclusive. The trading restriction applies to promoters, designated persons, directors, and their immediate relatives, in compliance with SEBI regulations.